First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

We'd like our readers to start paying for Daily Maverick

More specifically, we'd like those who can afford to pay to start paying. What it comes down to is whether or not you value Daily Maverick. Think of us in terms of your daily cappuccino from your favourite coffee shop. It costs around R35. That’s R1,050 per month on frothy milk. Don’t get us wrong, we’re almost exclusively fuelled by coffee. BUT maybe R200 of that R1,050 could go to the journalism that’s fighting for the country?

We don’t dictate how much we’d like our readers to contribute. After all, how much you value our work is subjective (and frankly, every amount helps). At R200, you get it back in Uber Eats and ride vouchers every month, but that’s just a suggestion. A little less than a week’s worth of cappuccinos.

We can't survive on hope and our own determination. Our country is going to be considerably worse off if we don’t have a strong, sustainable news media. If you’re rejigging your budgets, and it comes to choosing between frothy milk and Daily Maverick, we hope you might reconsider that cappuccino.

We need your help. And we’re not ashamed to ask for it.

Our mission is to Defend Truth. Join Maverick Insider.

Support Daily Maverick→
Payment options

Germany to Offer Covid Shots to Youngsters as Vaccinati...



Germany to Offer Covid Shots to Youngsters as Vaccinations Slow

Vials of the Pfizer-BioNTech Covid-19 vaccine. (Archive photo: Liesa Johannssen-Koppitz/Bloomberg)
By Bloomberg
02 Aug 2021 0

(Bloomberg) --Germany is poised to widen Covid-19 vaccinations to include all 12-17 year-olds, stepping up efforts to spur its flagging inoculation drive.

By Iain Rogers
Aug 2, 2021, 9:30 AM – Updated on Aug 2, 2021, 9:30 AM
Word Count: 322

The move set to be agreed Monday goes beyond advice published by the government’s independent vaccine commission. The authority, known as STIKO, recommends inoculating those in that age group who have pre-existing conditions that put them at heightened risk from the coronavirus, or those who are in regular contact with people who are in particular danger.

“In other countries this is already happening and we think it’s important not to lose any time,” Bavaria Health Minister Klaus Holetschek said Monday in an interview with ARD television.

“If anyone is unsure, they should consult their doctor,” he added ahead of talks with regional counterparts and Federal Health Minister Jens Spahn. “The key thing is that we’re making an offer of vaccines to a group that is not yet protected.”

The European Medicines Agency, which monitors and supervises the safety of medicines in the European Union, has recommended giving either the Pfizer Inc./BioNTech SE or the Moderna Inc. Covid-19 shots to 12-17 year-olds.

Germany’s STIKO has been more cautious, arguing that safety studies of the vaccine for young people aren’t yet extensive enough to allow a recommendation for general use, given that most Covid cases in teens are mild.

As of Friday, 52% of the German population were fully vaccinated against Covid-19, and just under 62% had received at least one shot, according to the latest health ministry data.

The inoculation campaign has lost steam in recent weeks. In May and June, Germany was regularly vaccinating more than 1 million people per day, but the total has fallen back significantly since the start of July.

Read our QuickTake explainers:
Are Covid Shots Working? What the Real World Tells Us: QuickTake
Can I Be Required to Get Vaccinated Against Covid-19?: QuickTake
What Makes Delta the Most Disruptive Virus Variant: QuickTake

–With assistance from Naomi Kresge.

© 2021 Bloomberg L.P.

Information pertaining to Covid-19, vaccines, how to control the spread of the virus and potential treatments is ever-changing. Under the South African Disaster Management Act Regulation 11(5)(c) it is prohibited to publish information through any medium with the intention to deceive people on government measures to address COVID-19. We are therefore disabling the comment section on this article in order to protect both the commenting member and ourselves from potential liability. Should you have additional information that you think we should know, please email [email protected]

Please peer review 3 community comments before your comment can be posted